BE study with two different batches of the reference product [Study As­sess­ment]

posted by jag009  – NJ, 2014-12-16 16:24 (4209 d 08:31 ago) – Posting: # 14086
Views: 10,890

Hi,

❝ In a two period, single dose, cross over, BE study, it was observd that after completion of period-I, there was insufficient quantity of the reference product available to dose subjects in period-II. sponsor also doesnt have same batch reference product availalbe with them.


FDA? Good luck.
Best thing to do is file a control correspondence and keep your fingers crossed.

John

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,571 registered users;
144 visitors (0 registered, 144 guests [including 22 identified bots]).
Forum time: 01:55 CEST (Europe/Vienna)

The great tragedy of Science – the slaying
of a beautiful hypothesis by an ugly fact.    Thomas Henry Huxley

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5